Overview
RedShiftBio provides analytical instrumentation using Microfluidic Modulation Spectroscopy (MMS) and Liquid Chromatography (HaLCon) for protein and RNA analysis in drug development. Their Aurora TX and AQS3pro systems enable ultra-sensitive measurements of biomolecule structure, stability, aggregation, and concentration across wide ranges without dilution. These tools support bioprocessing, formulation, and characterization for therapeutic modalities including proteins and RNA.
Frequently asked questions
- What core technologies does RedShiftBio offer for biomolecule analysis?
- RedShiftBio offers Microfluidic Modulation Spectroscopy (MMS) for structure, stability, and aggregation analysis, and HaLCon Liquid Chromatography for real-time protein titer measurement in bioprocessing.
- What capabilities does the Aurora TX provide for RNA and protein analysis?
- Aurora TX uses MMS with thermal ramping for ultra-sensitive, automated measurements of RNA and protein structure, stability under temperature stress, and aggregation in native buffers across wide concentrations.
- What applications are supported by RedShiftBio instruments in pharma R&D?
- Instruments support drug discovery, development, and manufacturing by measuring critical quality attributes like structure, stability, titer, and aggregation for proteins, RNA, and other therapeutics.